1478 related articles for article (PubMed ID: 25153927)
21. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
[TBL] [Abstract][Full Text] [Related]
22. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.
Mekonnen F; Tessema B; Moges F; Gelaw A; Eshetie S; Kumera G
BMC Infect Dis; 2015 Oct; 15():461. PubMed ID: 26503269
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of drug resistance in Mycobacterium tuberculosis.
Zhang Y; Yew WW
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
[TBL] [Abstract][Full Text] [Related]
25. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India.
Maurya AK; Kant S; Nag VL; Kushwaha RA; Dhole TN
J Postgrad Med; 2012; 58(3):185-9. PubMed ID: 23023350
[TBL] [Abstract][Full Text] [Related]
26. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
Reechaipichitkul W
Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
[TBL] [Abstract][Full Text] [Related]
27. Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.
Chaiprasert A; Srimuang S; Tingtoy N; Makhao N; Sirirudeeporn P; Tomnongdee N; Theankeaw O; Charoensook S; Leechawengwongs M; Prammananan T
Int J Tuberc Lung Dis; 2014 Aug; 18(8):961-3. PubMed ID: 25199012
[TBL] [Abstract][Full Text] [Related]
28. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
29. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J
Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909
[TBL] [Abstract][Full Text] [Related]
30. Tuberculosis in Europe: a problem of drug resistance or much more?
Carvalho AC; Migliori GB; Cirillo DM
Expert Rev Respir Med; 2010 Apr; 4(2):189-200. PubMed ID: 20406085
[TBL] [Abstract][Full Text] [Related]
31. Multidrug-resistant tuberculosis: treatment is empirical, for want of robust trials.
Prescrire Int; 2014 Oct; 23(153):245-6. PubMed ID: 25964976
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
Ahmad S; Mokaddas E
Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
[TBL] [Abstract][Full Text] [Related]
33. [Multidrug resistant tuberculosis in Romania in the last years (2004-2007)--an extremely important social phenomenon].
Marica C; Didilescu C; Chiotan D; Galie N; Tănăsescu M; Popescu-Hagen M; Popa M
Pneumologia; 2008; 57(4):195-200. PubMed ID: 19186681
[TBL] [Abstract][Full Text] [Related]
34. Drug-resistant tuberculosis: past, present, future.
Chiang CY; Centis R; Migliori GB
Respirology; 2010 Apr; 15(3):413-32. PubMed ID: 20337989
[TBL] [Abstract][Full Text] [Related]
35. Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.
Tabarsi P; Chitsaz E; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Amiri M; Mansouri D; Masjedi MR; Velayati AA; Caminero JA
Microb Drug Resist; 2010 Mar; 16(1):81-6. PubMed ID: 20192820
[TBL] [Abstract][Full Text] [Related]
36. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
[TBL] [Abstract][Full Text] [Related]
37. [Drug resistant tuberculosis].
Zwolska Z; Augustynowicz-Kopeć E
Pol Merkur Lekarski; 2011 May; 30(179):362-6. PubMed ID: 21675144
[TBL] [Abstract][Full Text] [Related]
38. Classical against molecular-genetic methods for susceptibility testing of antituberculotics.
Porvaznik I; Mokry J; Solovic I
Adv Exp Med Biol; 2015; 835():15-22. PubMed ID: 25252893
[TBL] [Abstract][Full Text] [Related]
39. Primary drug resistance to anti-tuberculosis drugs in major towns of Amhara region, Ethiopia.
Yimer SA; Agonafir M; Derese Y; Sani Y; Bjune GA; Holm-Hansen C
APMIS; 2012 Jun; 120(6):503-9. PubMed ID: 22583363
[TBL] [Abstract][Full Text] [Related]
40. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
